drugset / Trial / NCT05550207
Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label trial to evaluate the efficacy and safety of AXS-07 in subjects with migraine attacks and prior inadequate response to oral CGRP inhibitors.
Timeline
- Start
- 2022-08-31
- Primary completion
- 2024-11-27
- Completion
- 2024-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meloxicam | Small molecule | — | Oral |
| Subject | rizatriptan | Unknown | — | Oral |